Kent Wellish MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL) (NCT04731727) | Kent Wellish MD | 2021-06-30 |
Track Kent Wellish MD automatically
Every clearance here is in the API, with alerts when new ones post.